Skip to content

Clinical trials

Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Country / region: Hong Kong Clear all

135 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20075
20083
20093
20106
20115
20122
20131
20147
20155
20162
20179
20187
201913
20205
20219
20227
202311
202414
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting31
Active, not recruiting15
Terminated15
Unknown status11
Not yet recruiting4
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong30
Chinese University of Hong Kong15
Amgen9
The Hong Kong Polytechnic University9
Novartis Pharmaceuticals7
Hoffmann-La Roche5
Bayer4
Merck Sharp & Dohme LLC4
GlaxoSmithKline3
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms135
Carcinoma, Non-Small-Cell Lung16
Carcinoma, Hepatocellular12
Carcinoma11
Colorectal Neoplasms9
Neoplasm Metastasis9
Neoplasms by Site9
Lung Neoplasms8
Neoplasms by Histologic Type8
Breast Neoplasms7

Trials

Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.

35 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.